Immunocore Holdings reported revenue of $115.93M and net income of -$0.81M for the quarter ended Jun 2026, up 18.3% year over year. This income statement covers 21 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2019 | Dec2020 | Sep2021 | Dec2021 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||
| Revenue | 8.17M | 8.89M | 40.30M | 48.56M | 56.37M | 54.66M | 59.76M | 64.85M | 70.16M | 70.50M | 75.40M | 80.25M | 84.05M | 93.88M | 97.96M | 103.69M | 104.48M | 106.68M | 115.93M | ||
| Cost of RevenueCost of Rev | 0.31M | 0.07M | 0.13M | 0.22M | 0.35M | 0.28M | 0.20M | 0.25M | 1.71M | 0.45M | 0.33M | 0.83M | 1.04M | 0.51M | 2.70M | 0.43M | 1.09M | ||||
| Gross Profit | 8.17M | 8.89M | 39.99M | 48.48M | 56.25M | 54.44M | 58.66M | 64.57M | 69.96M | 70.26M | 73.69M | 79.80M | 83.72M | 93.05M | 96.92M | 103.18M | 101.78M | 106.24M | 114.84M | ||
| Operating items | |||||||||||||||||||||
| Research & DevelopmentR&D | 23.16M | 27.06M | 25.38M | 27.46M | 31.83M | 36.57M | 38.16M | 43.25M | 45.56M | 57.46M | 51.07M | 52.77M | 60.85M | 56.47M | 69.01M | 70.57M | 78.82M | 61.11M | 73.94M | ||
| Selling, General & AdministrativeSG&A | 27.64M | 32.85M | 25.32M | 13.75M | 50.60M | 32.57M | 42.40M | 35.47M | 41.45M | 39.29M | 38.64M | 35.53M | 42.32M | 40.20M | 42.79M | 39.78M | 42.65M | 37.85M | 43.89M | ||
| Operating ExpensesOpex | 50.80M | 59.90M | 50.69M | 41.21M | 82.43M | 69.14M | 78.40M | 78.72M | 87.01M | 96.75M | 89.71M | 88.30M | 103.17M | 96.67M | 111.80M | 110.35M | 121.47M | 98.96M | 117.83M | ||
| Operating IncomeOp. Inc | -42.67M | -51.00M | -20.73M | 7.27M | -26.19M | -14.70M | -13.76M | -14.14M | -17.05M | -26.49M | -16.02M | -8.50M | -19.45M | -3.62M | -14.88M | -7.17M | -19.69M | 7.28M | -3.00M | ||
| EBIT | -42.67M | -51.00M | -20.73M | 7.27M | -26.19M | -14.70M | -19.74M | -14.14M | -17.05M | -26.49M | -16.02M | -8.50M | -19.45M | -3.62M | -14.88M | -7.17M | -19.69M | 7.28M | -3.00M | ||
| Non-operating items | |||||||||||||||||||||
| Non Operating Interest Expenses | 1.82M | 1.82M | 1.76M | 2.10M | 3.73M | 1.25M | 1.27M | 1.32M | 1.31M | 3.24M | 4.28M | 4.29M | 7.04M | 3.02M | 3.04M | 3.04M | 3.05M | 3.05M | 3.06M | ||
| Interest & Investment IncomeInt & Inv Inc | 0.01M | 0.01M | 0.15M | 0.70M | 2.85M | 3.13M | 4.28M | 5.14M | 5.44M | 8.25M | 6.24M | 5.96M | 5.17M | 4.18M | 4.27M | 4.12M | 3.91M | 3.42M | 3.58M | ||
| Other Non Operating IncomeOther Non Op Inc. | -6.01M | -5.88M | 11.25M | -12.47M | -2.41M | 4.43M | 8.96M | 0.99M | 5.47M | 4.69M | 5.06M | 4.50M | 3.85M | 3.07M | |||||||
| Net income details | |||||||||||||||||||||
| EBT | -44.47M | -52.81M | -22.39M | 5.87M | -27.06M | -19.16M | -16.82M | 0.73M | -25.64M | -24.08M | -10.13M | 6.09M | -24.82M | 6.08M | -9.69M | 0.30M | -15.79M | 13.27M | -0.51M | ||
| Tax ProvisionsTaxes | -2.93M | 0.29M | -2.71M | -1.47M | 2.50M | 0.30M | 0.19M | -0.17M | -5.91M | 0.40M | 1.50M | -2.64M | -1.05M | 1.10M | 0.61M | 0.50M | 14.27M | 0.30M | 0.30M | ||
| Profit After TaxPAT | -41.54M | -53.10M | -20.31M | 7.34M | -29.56M | -19.45M | -17.01M | -14.04M | -18.98M | -24.44M | -11.62M | 11.98M | -23.77M | 5.02M | -10.30M | -3.57M | -30.06M | 12.97M | -0.81M | ||
| Income from Continuing OperationsIncome (Continuing) | -41.54M | -53.10M | -19.69M | 7.34M | -29.56M | -19.46M | -17.62M | 0.91M | -19.73M | -24.48M | -11.63M | 8.74M | -23.77M | 4.98M | -10.30M | -0.20M | -30.06M | 12.97M | -0.81M | ||
| Consolidated Net IncomeConsol Net Inc. | -41.54M | -53.10M | -19.69M | 7.34M | -29.56M | -19.46M | -17.62M | 0.91M | -19.73M | -24.48M | -11.63M | 8.74M | -23.77M | 4.98M | -10.30M | -0.20M | -30.06M | 12.97M | -0.81M | ||
| Income towards Parent CompanyParent Net Inc | -41.54M | -53.10M | -19.69M | 7.34M | -29.56M | -19.46M | -17.62M | 0.91M | -19.73M | -24.48M | -11.63M | 8.74M | -23.77M | 4.98M | -10.30M | -0.20M | -30.06M | 12.97M | -0.81M | ||
| Net Income towards Common StockholdersNet Income | -41.54M | -53.10M | -19.69M | 7.34M | -29.56M | -19.46M | -17.62M | 0.91M | -19.73M | -24.48M | -11.63M | 8.74M | -23.77M | 4.98M | -10.30M | -0.20M | -30.06M | 12.97M | -0.81M | ||
| Additional items | |||||||||||||||||||||
| EPS (Basic) | -1.57 | -1.25 | -0.46 | 0.17 | -0.65 | -0.40 | -0.36 | 0.02 | -0.40 | -0.49 | -0.23 | 0.17 | -0.48 | 0.10 | -0.20 | 0.00 | -0.60 | 0.26 | -0.02 | ||
| EPS (Diluted) | -1.57 | -1.25 | -0.46 | 0.17 | -0.65 | -0.40 | -0.36 | 0.02 | -0.40 | -0.49 | -0.23 | 0.17 | -0.48 | 0.10 | -0.20 | 0.00 | -0.60 | 0.25 | -0.02 | ||
| Shares Outstanding | 26.52M | 26.52M | 42.49M | 42.49M | 42.49M | 45.71M | 48.18M | 48.69M | 49.13M | 48.89M | 49.88M | 50.01M | 50.02M | 49.99M | 50.09M | 50.29M | 50.40M | 50.35M | 50.75M | 50.97M | |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 26.52M | 26.52M | 42.49M | 42.49M | 42.49M | 45.71M | 48.18M | 48.69M | 54.16M | 48.89M | 49.88M | 50.01M | 52.81M | 49.99M | 51.95M | 50.29M | 50.40M | 50.35M | 52.93M | 50.97M | |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 31.78M | 43.86M | 48.09M | 48.38M | 48.94M | 50.29M | 49.73M | 50.01M | 50.02M | 50.03M | 50.06M | 50.18M | 50.37M | 50.47M | 50.69M | 50.83M | 51.48M | ||||
| EBITDA | -42.67M | -51.00M | -20.73M | 7.27M | -26.19M | -14.70M | -19.74M | -14.14M | -17.05M | -26.49M | -16.02M | -8.50M | -19.45M | -3.62M | -14.88M | -7.17M | -19.69M | 7.28M | -3.00M | ||
| Interest ExpensesInt Expense | 1.82M | 1.82M | 1.76M | 2.10M | 3.73M | 1.25M | 1.96M | 1.32M | 1.31M | 3.24M | 4.28M | 4.29M | 7.04M | 3.02M | 3.04M | 3.04M | 3.05M | 3.05M | 3.06M | ||
| Tax Rate | 6.59% | -0.55% | 12.10% | -24.96% | -9.23% | -1.57% | -1.14% | -23.94% | 23.05% | -1.66% | -14.81% | -43.38% | 4.23% | 18.08% | -6.25% | 164.47% | -90.33% | 2.27% | -58.37% |